Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

B Scatton, H Loo, T Dennis

    Psychopharmacology
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers.

    Translational psychiatry·2016
    Same author

    Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.

    NeuroImage·2014
    Same author

    Tryptophan hydroxylase(2) gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans.

    Molecular psychiatry·2011
    Same author

    Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.

    Neuroscience·2008
    Same author

    Peripheral type benzodiazepine binding sites as a tool for the detection and quantification of CNS injury.

    Current protocols in neuroscience·2008
    Same author

    New perspectives for the treatment of disorders of sleep and arousal.

    Annales pharmaceutiques francaises·2007
    Same journal

    Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice.

    Psychopharmacology·2026
    Same journal

    Cannabidiol in the anterior insular cortex attenuates chronic neuropathic pain and comorbid anxiety- and depression-like behaviors: involvement of CB<sub>1</sub> and 5-HT<sub>1A</sub> receptor signaling.

    Psychopharmacology·2026
    Same journal

    Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.

    Psychopharmacology·2026
    Same journal

    Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.

    Psychopharmacology·2026
    Same journal

    Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

    Psychopharmacology·2026
    Same journal

    OPRD1 rs4654327 and Outcomes of Extended-Release Naltrexone in Alcohol Use Disorder: An Exploratory Prospective Pharmacogenetic Study.

    Psychopharmacology·2026
    See all related articles

    Depressed patients show lower plasma levels of 3,4-dihydroxyphenylethyleneglycol (DOPEG), a norepinephrine metabolite. This finding suggests reduced central nervous system noradrenergic transmission in major depression.

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Psychiatry

    Background:

    • Norepinephrine is a key neurotransmitter implicated in mood regulation.
    • 3,4-dihydroxyphenylethyleneglycol (DOPEG) is the primary deaminated metabolite of norepinephrine.
    • Altered noradrenergic function is hypothesized in major depressive disorder.

    Purpose of the Study:

    • To investigate plasma levels of free and sulfoconjugated DOPEG in patients with major depression compared to healthy controls.
    • To explore the relationship between DOPEG levels and depression severity, duration of drug-free period, sex, and patient type (unipolar/bipolar).

    Main Methods:

    • Plasma samples were collected from 45 hospitalized major depression patients and 45 matched healthy controls.
    • Levels of free and sulfoconjugated DOPEG were quantified using [specific assay not mentioned in abstract].

    Related Experiment Videos

  • Statistical analyses were performed to compare groups and assess correlations.

    • Main Results:

    • Depressed patients exhibited significantly lower plasma levels of both free and sulfoconjugated DOPEG compared to healthy subjects.
    • The ratio of free to sulfoconjugated DOPEG did not differ between groups.
    • DOPEG levels were not correlated with depression severity (Hamilton Scale), drug-free period duration, sex, or unipolar/bipolar status.

    Conclusions:

    • Reduced plasma DOPEG levels in major depression support the hypothesis of diminished central nervous system noradrenergic transmission.
    • DOPEG may serve as a potential biomarker for noradrenergic dysfunction in depression.
    • Further research is warranted to elucidate the precise role of noradrenergic pathways in the pathophysiology of depression.